Amyloid Mild Cognitive Impairment (MCI) clinical trials
12 active Mild Cognitive Impairment (MCI) trials that test for Amyloid in their eligibility criteria. Describe your situation to see which ones look like a fit.
- Stem Cell Therapy for Early Alzheimer's Disease
- Innate Immunity Stimulation Via TLR9 in Early AD
- TREAD: Time Restricted Eating Intervention for Alzheimer's Disease
- A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
- A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
- Development of a Home Test for Measuring Blood P-tau217 in Alzheimer's Disease Using the Tasso Lancet Device
- 2-Hydroxybenzylamine (2-HOBA) Study in Early Alzheimer's Patients
- Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?
- TMS Pilot in Early AD II
- Georgia Memory Net Anti-Amyloid Monoclonal Antibody Registry
- Tau PET Outcomes With Anti-amyloid Immunotherapies
- Rapamycin - Effects on Alzheimer's and Cognitive Health
← All Mild Cognitive Impairment (MCI) trials
Guides for people searching for a trial
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.